Healthcare and entitlement reform expert Avik Roy sees two major problems in healthcare today: overly high drug prices and a bottleneck at the FDA. Progress, he argues, isn't about health insurance but the innovation occurring in drug development. Echoing President-elect Trump, Roy would like to see more free market options to combat the rising cost of drugs, as well as a more streamlined drug-approval process.
About Avik Roy
Transcending Obamacare and Forbes.
Contact Us
Enter your contact information below and a member of our team will reach out to you shortly.